<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Aptalis Pharma Canada ULC et al v. Par Pharmaceutical, Inc. :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2016cv01069/60726</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2016cv01069/60726/feed" rel="self" type="application/rss+xml" />
        <pubDate>Fri, 06 Nov 2026 19:38:07 -0800</pubDate>
        <lastBuildDate>Fri, 06 Nov 2026 19:38:07 -0800</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Aptalis Pharma Canada ULC et al v. Par Pharmaceutical, Inc. - Docket Entries - Showing 1 through 10</description>
                                    <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (Attachments: #1 Stipulation of dismissal)(nmfn) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038698</guid>
                <pubDate>
            Wed, 19 Apr 2017 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #9 Stipulation of Dismissal filed by Aptalis Pharma Canada ULC, Allergan USA, Inc., Forest Laboratories, LLC, (CASE CLOSED). Signed by Judge Sue L. Robinson on 4/19/2017. (nmfn) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038697</guid>
                <pubDate>
            Wed, 19 Apr 2017 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION of Dismissal by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (Blumenfeld, Jack) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038696</guid>
                <pubDate>
            Tue, 18 Apr 2017 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 - filed by Par Pharmaceutical, Inc.. (Pascale, Karen) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038694</guid>
                <pubDate>
            Wed, 29 Mar 2017 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #8 STIPULATION TO EXTEND TIME to ANSWER Complaint to May 4, 2017 filed by Par Pharmaceutical, Inc., Set/Reset Answer Deadlines: Par Pharmaceutical, Inc. answer due 5/4/2017. Signed by Judge Sue L. Robinson on 3/29/2017. (fms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038695</guid>
                <pubDate>
            Wed, 29 Mar 2017 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                WAIVER OF SERVICE returned executed by Forest Laboratories, LLC, Aptalis Pharma Canada ULC, Allergan USA, Inc.: For Par Pharmaceutical, Inc. waiver sent on 2/1/2017, answer due 4/3/2017. (Noreika, Maryellen) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038693</guid>
                <pubDate>
            Wed, 01 Feb 2017 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                REQUEST FOR WAIVER of Service sent to Par Pharmaceutical, Inc. on 2/1/2017 by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. Waiver of Service due by 3/3/2017. (Noreika, Maryellen) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038692</guid>
                <pubDate>
            Wed, 01 Feb 2017 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038691</guid>
                <pubDate>
            Wed, 23 Nov 2016 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC filed by Allergan USA, Inc., Aptalis Pharma Canada ULC, Forest Laboratories, LLC. (nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038689</guid>
                <pubDate>
            Fri, 18 Nov 2016 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,350,468 B1. (nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038688</guid>
                <pubDate>
            Fri, 18 Nov 2016 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/7/2016. Date of Expiration of Patent: 12/14/2018.Thirty Month Stay Deadline: 4/7/2019. (nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038687</guid>
                <pubDate>
            Fri, 18 Nov 2016 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038686</guid>
                <pubDate>
            Fri, 18 Nov 2016 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT for PATENT INFRINGEMENT filed against Par Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2033068.) - filed by Forest Laboratories, LLC, Aptalis Pharma Canada ULC, Allergan USA, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038685</guid>
                <pubDate>
            Fri, 18 Nov 2016 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Summons Issued with Magistrate Consent Notice attached as to Par Pharmaceutical, Inc. on 11/21/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16038690</guid>
                <pubDate>
            Fri, 18 Nov 2016 00:00:00 -0800
        </pubDate>
    </item>
                </channel>
</rss>
